Luke Ascolillo

Luke Ascolillo has extensive experience in clinical operations, currently serving as Senior Director of Clinical Operations at Dragonfly Therapeutics, Inc. since April 2025. Prior to this role, Ascolillo held the position of Senior Director of Clinical Operations at Alpha-9 Oncology from March 2023 to April 2025 and was the Director of Clinical Operations at Hemab Therapeutics from October 2021 to March 2023. Ascolillo's career also includes significant positions at Codiak BioSciences, where responsibilities spanned Director of Clinical Operations and Translational Biomarkers, Associate Director of Clinical Operations, and Senior Project Manager. Previous experience includes Senior Project Manager at Genocea Biosciences and various roles at Tufts University, including Research Program Manager and Project Manager. Ascolillo's educational background comprises a Master of Science in Engineering from Tufts University, a Master of Public Health in Environmental Health from Tufts University School of Medicine, and a Bachelor of Science in Biochemistry/Biophysics from Rensselaer Polytechnic Institute.